---

$4.56

+0.2150 ( +4.95% ) 30.0K

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-11-28	Sale	-150000.00	Badawi David
2023-11-22	Buy	79234.00	Encrantz Staffan
2023-11-20	Buy	339.00	Encrantz Staffan
2023-11-16	Sale	-747572.00	Link Matthew
2023-11-16	Buy	3462.00	Encrantz Staffan
2023-09-15	Sale	-31668.00	Park Sam Boong